James L. LaBelle to Hemoglobin, Sickle
This is a "connection" page, showing publications James L. LaBelle has written about Hemoglobin, Sickle.
Connection Strength
0.227
-
CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease. N Engl J Med. 2023 Aug 31; 389(9):820-832.
Score: 0.227